Johanna Holldack

Johanna Holldack is a seasoned executive with extensive leadership experience in the biotechnology and pharmaceutical sectors. Since May 2018, Holldack has served as the CEO and Founder of Kupando GmbH. Prior to this, Holldack was a Board Member at Photocure ASA from April 2017 to May 2024 and Chairman at Amal Therapeutics until its acquisition by Boehringer Ingelheim in July 2019. Additional roles include President and CEO at Trethera Corporation (2015-2017), CEO at Telormedix (2009-2015), and CEO at Borean Pharma (2003-2008). Holldack's early career included positions as COO at MediGene AG (1999-2003), VP at Chiron Corporation (1997-1999), and various roles in clinical research, project management, and regulatory affairs at Behringwerke (1990-1997). Holldack's diverse background reflects a strong commitment to advancing the life sciences industry.